Literature DB >> 19412424

Modeling Adult Gliomas Using RCAS/t-va Technology.

Dolores Hambardzumyan1, Nduka M Amankulor, Karim Y Helmy, Oren J Becher, Eric C Holland.   

Abstract

Malignant gliomas remain the most devastating childhood and adult tumors of the central nervous system. Although adult and pediatric gliomas are histologically indistinguishable, they differ in location, behavior, and molecular characteristics. This implies that the molecular pathways and pathophysiology of malignant gliomagenesis in these two populations are distinct. Such differences between adult and pediatric gliomas may predict different therapeutic responses. Therefore, accurate genetically engineered models of adult and pediatric gliomas may help understand the biology of these tumors and evaluate therapeutic agents in preclinical studies. It has been proposed that gliomas arise from the subventricular zone in mice during development. Here, we demonstrate that, in adult mice, gliomas may arise not only when injected in the subventricular zone but also when injected in the cortex and cerebellum. Our work demonstrates a versatile and highly reproducible adult mouse model of glioma, which can be easily incorporated into preclinical studies.

Entities:  

Year:  2009        PMID: 19412424      PMCID: PMC2670576          DOI: 10.1593/tlo.09100

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  45 in total

Review 1.  Platelet-derived growth factor (PDGF) and glial tumorigenesis.

Authors:  Alan H Shih; Eric C Holland
Journal:  Cancer Lett       Date:  2005-08-31       Impact factor: 8.679

2.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

Authors:  Jeongwu Lee; Svetlana Kotliarova; Yuri Kotliarov; Aiguo Li; Qin Su; Nicholas M Donin; Sandra Pastorino; Benjamin W Purow; Neil Christopher; Wei Zhang; John K Park; Howard A Fine
Journal:  Cancer Cell       Date:  2006-05       Impact factor: 31.743

3.  CNTF and its receptor subunits in human gliomas.

Authors:  J Weis; L M Schönrock; S L Züchner; D C Lie; U Sure; C Schul; F Stögbauer; E B Ringelstein; H Halfter
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

4.  Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.

Authors:  Ian F Pollack; Ronald L Hamilton; C David James; Sydney D Finkelstein; Judith Burnham; Allan J Yates; Emiko J Holmes; Tianni Zhou; Jonathan L Finlay
Journal:  J Neurosurg       Date:  2006-11       Impact factor: 5.115

Review 5.  Mouse models of brain tumors and their applications in preclinical trials.

Authors:  Elena I Fomchenko; Eric C Holland
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

Review 6.  Tumorigenesis in the brain: location, location, location.

Authors:  Richard J Gilbertson; David H Gutmann
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

7.  Genetically engineered models have advantages over xenografts for preclinical studies.

Authors:  Oren J Becher; Eric C Holland
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

8.  Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin.

Authors:  Mukesh K Sharma; David B Mansur; Guido Reifenberger; Arie Perry; Jeffrey R Leonard; Kenneth D Aldape; Meredith G Albin; Ryan J Emnett; Simon Loeser; Mark A Watson; Rakesh Nagarajan; David H Gutmann
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

9.  Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model.

Authors:  Sheila Alcantara Llaguno; Jian Chen; Chang-Hyuk Kwon; Erica L Jackson; Yanjiao Li; Dennis K Burns; Arturo Alvarez-Buylla; Luis F Parada
Journal:  Cancer Cell       Date:  2009-01-06       Impact factor: 31.743

10.  Incidence of gliomas by anatomic location.

Authors:  Suvi Larjavaara; Riitta Mäntylä; Tiina Salminen; Hannu Haapasalo; Jani Raitanen; Juha Jääskeläinen; Anssi Auvinen
Journal:  Neuro Oncol       Date:  2007-05-23       Impact factor: 12.300

View more
  130 in total

1.  Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.

Authors:  Tyler C Steed; Jeffrey M Treiber; Birra Taha; H Billur Engin; Hannah Carter; Kunal S Patel; Anders M Dale; Bob S Carter; Clark C Chen
Journal:  J Neurooncol       Date:  2020-06-15       Impact factor: 4.130

2.  Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma.

Authors:  Forrest M Kievit; Kui Wang; Tatsuya Ozawa; Aria W Tarudji; John R Silber; Eric C Holland; Richard G Ellenbogen; Miqin Zhang
Journal:  Nanomedicine       Date:  2017-06-11       Impact factor: 5.307

Review 3.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurosci       Date:  2011-08-03       Impact factor: 34.870

4.  Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression.

Authors:  David Kozono; Jie Li; Masayuki Nitta; Oltea Sampetrean; David Gonda; Deepa S Kushwaha; Dmitry Merzon; Valya Ramakrishnan; Shan Zhu; Kaya Zhu; Hiroko Matsui; Olivier Harismendy; Wei Hua; Ying Mao; Chang-Hyuk Kwon; Hideyuki Saya; Ichiro Nakano; Donald P Pizzo; Scott R VandenBerg; Clark C Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-09       Impact factor: 11.205

5.  Lentiviral-induced high-grade gliomas in rats: the effects of PDGFB, HRAS-G12V, AKT, and IDH1-R132H.

Authors:  John Lynes; Mia Wibowo; Carl Koschmann; Gregory J Baker; Vandana Saxena; A K M G Muhammad; Niyati Bondale; Julia Klein; Hikmat Assi; Andrew P Lieberman; Maria G Castro; Pedro R Lowenstein
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

6.  Low Concentration Microenvironments Enhance the Migration of Neonatal Cells of Glial Lineage.

Authors:  Richard A Able; Celestin Ngnabeuye; Cade Beck; Eric C Holland; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2012-06       Impact factor: 2.321

Review 7.  Mouse models of glioblastoma: lessons learned and questions to be answered.

Authors:  Loury Janbazian; Jason Karamchandani; Sunit Das
Journal:  J Neurooncol       Date:  2014-02-13       Impact factor: 4.130

Review 8.  Brain tumors across the age spectrum: biology, therapy, and late effects.

Authors:  Thomas E Merchant; Ian F Pollack; Jay S Loeffler
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

9.  Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production.

Authors:  Tommy Alain; XueQing Lun; Yvan Martineau; Polen Sean; Bali Pulendran; Emmanuel Petroulakis; Franz J Zemp; Chantal G Lemay; Dominic Roy; John C Bell; George Thomas; Sara C Kozma; Peter A Forsyth; Mauro Costa-Mattioli; Nahum Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

10.  The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.

Authors:  Daniela F Quail; Robert L Bowman; Leila Akkari; Marsha L Quick; Alberto J Schuhmacher; Jason T Huse; Eric C Holland; James C Sutton; Johanna A Joyce
Journal:  Science       Date:  2016-05-20       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.